GPCR Q1 2025 Earnings — Structure Therapeutics Inc. Revenue & Financial Results | Market Cap Arena

GPCRStructure Therapeutics Inc.

$3B

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$56M

Net Income

-$47M

EPS (Diluted)

$-0.81

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$52M

Free Cash Flow

-$53M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$867M

Total Liabilities

$42M

Stockholders' Equity

$825M

Cash & Equivalents

$152M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$56M	-$32M	-75.9%
Net Income	-$47M	-$26M	-79.9%